With devices that target cancer, heart failure and stroke, this week’s funding is making real change in emergency healthcare settings. The Leo Cancer Care radiotherapy system delivers an innovative, upright patient positioning for cancer care, while Axon is aiming to transform heart failure with Splanchnic Ablation for Volume Management. We are keeping a close eye on all the technologies featured this week – we’d suggest you do as well.
Leo Cancer Care raised $40m for radiotherapy system
The funding round was led by Catalio Capital Management and included participation from unspecified new and existing investors.
The funds will support its innovative, 510(k) clearance upright radiotherapy system named Marie, which enables a cancer treatment featuring upright patient positioning.
Co-founder and CEO Stephen Towe
Last week’s tracker: Microbot, Nalu & more
Axon Therapies raises $32m funding to transform heart failure treatment
The clinical-stage medical device company is pioneering a new approach to treating heart failure. The round was co-led by new investors Earlybird Venture Capital and Santé Ventures, with participation by existing investor Deerfield Management and new investors CD Capital and KOFA Healthcare.
It will accelerate Axon’s next phase of clinical development, aiming to offer a treatment alternative to heart failure patients.
Co-founder and CEO Zoar Engelman
Sunrise Group raises $29 Million to expand Dreem Health
The round was led by Eurazeo, with participation from Amazon’s Alexa Fund, WE International, Kurma Partners, Vives Fund, Majycc (an UI Investissement fund), Namur Invest, Seventure Partners, Investsud, Sambrinvest, Noshaq, IMBC and Invest.BW.
The funding will help expand Dreem Health’s nationwide growth, grow clinical services and invest in the next generation of sleep technology.
CEO and founder Laurent Martinot
Micro-X secures $4.4m government grant to bring Head CT stroke scanner into ambulances
Cold cathode X-ray technology company Micro-X has been awarded a $4.4 million grant by the Australian government’s Industry Growth Program to build and trial a world-first stroke-diagnosis-capable ambulance using its Head CT device.
After receiving the non-dilutive funding, the company plans a full patient imaging trial to collect data from stroke patients transported in the stroke ambulance.
CEO Kingsley Hall
Navigation Sciences receives $400,000 STTR grant from the National Cancer Institute to advance NaviSci System for precision lung cancer surgery
The Phase 1 Small Business Technology Transfer (STTR) grant from the National Cancer Institute will support the development of key technology for its NaviSci System for precision surgical resection of lung tumors.
The system aims to address a growing clinical need to reliably localize small, non-palpable tumors and resect them successfully.
CEO Alan Lucas
Bionto secures ¥60 million in seed funding
Tohoku University-based biotech startup bionto secured ¥60 million in seed funding through the issuance of J-KISS type stock options to PARTNERS FUND and a startup loan from the Japan Finance Corporation and The 77 Bank.
The latest round’s sole investor is PARTNERS FUND. The funds will be allocated towards the commercialisation of home healthcare devices, recruitment, and business development.
Sencilia secures funding to make infusion therapy safer and more precise
Dutch MedTech Sencilia is emerging as a promising player in advancing IV infusion therapy technology. Its latest funding round marks a significant step in scaling their innovation – the Rely-V sensor.
The investments came from Future Tech Ventures (FTV) and imec.istart.
Founder and CEO Amar Kamat
